Kurt Fernstrom

Array ( [id] => 6071495 [patent_doc_number] => 20110046346 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'BIOMATERIAL WITH FUNCTIONALISED SURFACES' [patent_app_type] => utility [patent_app_number] => 12/862233 [patent_app_country] => US [patent_app_date] => 2010-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4097 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20110046346.pdf [firstpage_image] =>[orig_patent_app_number] => 12862233 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9977524 [patent_doc_number] => 09023835 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-05 [patent_title] => 'Agent for ameliorating blood-brain barrier disorders' [patent_app_type] => utility [patent_app_number] => 13/390058 [patent_app_country] => US [patent_app_date] => 2010-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 9131 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13390058 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5959031 [patent_doc_number] => 20110183418 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-28 [patent_title] => 'Peptide-Polymer Cell Culture Articles and Methods of Making' [patent_app_type] => utility [patent_app_number] => 12/845411 [patent_app_country] => US [patent_app_date] => 2010-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13860 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20110183418.pdf [firstpage_image] =>[orig_patent_app_number] => 12845411 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8199273 [patent_doc_number] => 20120122772 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'Agent for Suppressing Elevation of Blood GIP Concentration' [patent_app_type] => utility [patent_app_number] => 13/383658 [patent_app_country] => US [patent_app_date] => 2010-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5801 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20120122772.pdf [firstpage_image] =>[orig_patent_app_number] => 13383658 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8186476 [patent_doc_number] => 20120115779 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-10 [patent_title] => 'AGENT FOR SUPPRESSING ELEVATION OF BLOOD TRIGLYCERIDE CONCENTRATION' [patent_app_type] => utility [patent_app_number] => 13/383633 [patent_app_country] => US [patent_app_date] => 2010-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3987 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20120115779.pdf [firstpage_image] =>[orig_patent_app_number] => 13383633 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9823541 [patent_doc_number] => 08933025 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-01-13 [patent_title] => 'Agent for suppressing postprandial elevation of blood insulin concentration' [patent_app_type] => utility [patent_app_number] => 13/383665 [patent_app_country] => US [patent_app_date] => 2010-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4729 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13383665 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8300972 [patent_doc_number] => 20120183531 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-19 [patent_title] => 'Methods for Inhibiting Yellow Color Formation in a Composition' [patent_app_type] => utility [patent_app_number] => 13/384178 [patent_app_country] => US [patent_app_date] => 2010-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 8975 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13384178 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6163019 [patent_doc_number] => 20110160149 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'Pharmaceutical Composition for a Hepatitis C Viral Protease Inhibitor' [patent_app_type] => utility [patent_app_number] => 12/830771 [patent_app_country] => US [patent_app_date] => 2010-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7794 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20110160149.pdf [firstpage_image] =>[orig_patent_app_number] => 12830771 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10128168 [patent_doc_number] => 09161988 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-20 [patent_title] => 'Multimeric peptide conjugates and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/382069 [patent_app_country] => US [patent_app_date] => 2010-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 40267 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13382069 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7651780 [patent_doc_number] => 20110301049 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'Fluid Flow Contour Control Using Flow Resistance' [patent_app_type] => utility [patent_app_number] => 12/794275 [patent_app_country] => US [patent_app_date] => 2010-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4795 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0301/20110301049.pdf [firstpage_image] =>[orig_patent_app_number] => 12794275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8253051 [patent_doc_number] => 20120157380 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-21 [patent_title] => 'PEGYLATED HUMAN APOA-1 AND PROCESS FOR PRODUCTION THEREOF' [patent_app_type] => utility [patent_app_number] => 13/376350 [patent_app_country] => US [patent_app_date] => 2010-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9279 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20120157380.pdf [firstpage_image] =>[orig_patent_app_number] => 13376350 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10857543 [patent_doc_number] => 08883741 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-11 [patent_title] => 'Stimulator of genital, sexual and reproductive function' [patent_app_type] => utility [patent_app_number] => 13/376023 [patent_app_country] => US [patent_app_date] => 2010-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9492 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13376023 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9778151 [patent_doc_number] => 08853359 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-07 [patent_title] => 'Endokinin C/D-derived peptides' [patent_app_type] => utility [patent_app_number] => 13/375668 [patent_app_country] => US [patent_app_date] => 2010-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 10323 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13375668 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6566091 [patent_doc_number] => 20100234244 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'USES AND METHODS OF MAKING MICROARRAYS OF POLYMERIC BIOMATERIALS' [patent_app_type] => utility [patent_app_number] => 12/788140 [patent_app_country] => US [patent_app_date] => 2010-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10781 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20100234244.pdf [firstpage_image] =>[orig_patent_app_number] => 12788140 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6400721 [patent_doc_number] => 20100304997 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'METHOD FOR DETECTING ABNORMAL SPOTS OF NUCLEIC ACID MICROARRAY' [patent_app_type] => utility [patent_app_number] => 12/787953 [patent_app_country] => US [patent_app_date] => 2010-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 27148 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0304/20100304997.pdf [firstpage_image] =>[orig_patent_app_number] => 12787953 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6266315 [patent_doc_number] => 20100298171 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'APPARATUS FOR POLYMER SYNTHESIS' [patent_app_type] => utility [patent_app_number] => 12/786287 [patent_app_country] => US [patent_app_date] => 2010-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 18481 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20100298171.pdf [firstpage_image] =>[orig_patent_app_number] => 12786287 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6400700 [patent_doc_number] => 20100304996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'B CELL SIGNATURE ASSOCIATED WITH TOLERANCE IN TRANSPLANT RECIPIENTS' [patent_app_type] => utility [patent_app_number] => 12/786068 [patent_app_country] => US [patent_app_date] => 2010-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 18170 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0304/20100304996.pdf [firstpage_image] =>[orig_patent_app_number] => 12786068 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7767834 [patent_doc_number] => 20120035097 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-09 [patent_title] => 'METHODS OF TREATING BACTERIAL INFECTIONS USING ORITAVANCIN' [patent_app_type] => utility [patent_app_number] => 12/740571 [patent_app_country] => US [patent_app_date] => 2010-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13002 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20120035097.pdf [firstpage_image] =>[orig_patent_app_number] => 12740571 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11198361 [patent_doc_number] => 09428564 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-08-30 [patent_title] => 'Muscle function enhancing peptide' [patent_app_type] => utility [patent_app_number] => 13/260862 [patent_app_country] => US [patent_app_date] => 2010-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 28533 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 169 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13260862 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6519906 [patent_doc_number] => 20100261877 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-14 [patent_title] => 'PROCESS FOR ISOLATING THERAPEUTIC PEPTIDES' [patent_app_type] => utility [patent_app_number] => 12/757357 [patent_app_country] => US [patent_app_date] => 2010-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6066 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20100261877.pdf [firstpage_image] =>[orig_patent_app_number] => 12757357 [rel_patent_id] =>[rel_patent_doc_number] =>)